Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer.
Reisenbichler ES, Han G, Bellizzi A, Bossuyt V, Brock J, Cole K, Fadare O, Hameed O, Hanley K, Harrison BT, Kuba MG, Ly A, Miller D, Podoll M, Roden AC, Singh K, Sanders MA, Wei S, Wen H, Pelekanou V, Yaghoobi V, Ahmed F, Pusztai L, Rimm DL.
Reisenbichler ES, et al. Among authors: harrison bt.
Mod Pathol. 2020 Sep;33(9):1746-1752. doi: 10.1038/s41379-020-0544-x. Epub 2020 Apr 16.
Mod Pathol. 2020.
PMID: 32300181
Free PMC article.